Bunn C C, Mathews M B
Cold Spring Harbor Laboratory, NY 11724.
Science. 1987 Nov 20;238(4830):1116-9. doi: 10.1126/science.2446387.
Autoantibodies to aminoacyl-transfer RNA (tRNA) synthetases are common in the human autoimmune diseases polymyositis and dermatomyositis. Sera of the PL-12 specificity contain separate antibodies reacting with alanyl-tRNA synthetase and alanine tRNA (tRNAAla). The antibodies to tRNA recognize at least six distinguishable human tRNAAla species grouped into two sequence families. The antibody-reactive determinants on the tRNA were identified through ribonuclease protection and oligonucleotide binding experiments. The antibody binding site is a seven- to nine-nucleotide sequence containing the anticodon loop and requires an intact anticodon. No requirement for anticodon stem structure or sequence is observed, although the 5' portion of the stem is protected from nuclease attack. Antibodies from several patients appear to share the same specificitym, indicating that the antibodies are induced by a unique sequence feature in the immunogen.
抗氨酰转移RNA(tRNA)合成酶自身抗体在人类自身免疫性疾病多发性肌炎和皮肌炎中很常见。具有PL - 12特异性的血清含有分别与丙氨酰 - tRNA合成酶和丙氨酸tRNA(tRNAAla)反应的抗体。针对tRNA的抗体识别至少六种可区分的人类tRNAAla种类,分为两个序列家族。通过核糖核酸酶保护和寡核苷酸结合实验确定了tRNA上的抗体反应决定簇。抗体结合位点是一个包含反密码子环的七至九个核苷酸序列,并且需要完整的反密码子。虽然茎的5'部分受到核酸酶攻击的保护,但未观察到对反密码子茎结构或序列的要求。来自几位患者的抗体似乎具有相同的特异性,这表明这些抗体是由免疫原中的独特序列特征诱导产生的。